NDUFA3P2

Across TCGA pan-cancer cohorts, NDUFA3P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated NDUFA3P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher NDUFA3P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NDUFA3P2 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

UVM, THYM, and BRCA are the cancer types where NDUFA3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.408	0.781	<.001	123	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	51	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
CHOL	DFS	Tertile	All	0.028	0.524	<.001	36	view →
MESO	DFS	Tertile	IV	0.073	0.381	<.001	27	view →
LIHC	DFS	Tertile	All	0.149	0.304	.018	24	view →
BLCA	OS	Quartile	II,III,IV	0.713	0.567	.013	23	view →
SKCM	DFS	Tertile	III,IV	0.273	0.519	.013	18	view →
ACC	DFS	Tertile	IV	0.050	0.405	.016	18	view →
TGCT	OS	Tertile	II,III,IV	0.802	1.000	.040	18	view →
KIRP	DFS	Quartile	All	0.751	0.896	.001	17	view →
LUAD	DFS	Quartile	II,III,IV	0.679	0.501	.015	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

NDUFA3P2–UVM (DFS)

Open the UVM breakdown →